Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ANI Pharmaceuticals Company Profile (NASDAQ:ANIP)

Consensus Ratings for ANI Pharmaceuticals (NASDAQ:ANIP) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $49.63 (9.84% downside)

Analysts' Ratings History for ANI Pharmaceuticals (NASDAQ:ANIP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/20/2014Roth CapitalBoost Price TargetBuy$55.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2014ZacksUpgradeNeutral -> Outperform$46.90ViewTweet This Rating  Share This Rating on StockTwits
10/1/2014ZacksUpgradeUnderperform -> Neutral$29.00ViewTweet This Rating  Share This Rating on StockTwits
9/2/2014ZacksDowngradeNeutral -> Underperform$27.90ViewTweet This Rating  Share This Rating on StockTwits
8/5/2014OppenheimerBoost Price Target$35.00 -> $37.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014OppenheimerReiterated RatingOutperform$40.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Roth CapitalBoost Price Target$36.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014OppenheimerBoost Price TargetOutperform$31.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2014Roth CapitalBoost Price Target$27.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2014OppenheimerBoost Price TargetOutperform$29.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
1/22/2014OppenheimerInitiated CoverageOutperform$29.00ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Roth CapitalInitiated CoverageBuy$27.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/22/2012 forward)